Bevacizumab for NF2-associated vestibular schwannomas of childhood and adolescence

Autor: Renzi S, Michaeli O, Salvador-Hernandez H, Alderete D, Ponce NF, Zapotocky M, Hansford JR, Malalasekera VS, Toledano H, Maguire B, Bouffet E, Ramaswamy V, Baroni LV

Publikováno v: PEDIATRIC BLOOD & CANCER
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu

Seventeen children at six institutions with neurofibromatosis type 2 (NF2)-related vestibular schwannomas received bevacizumab. Eight of the 13 patients with initial hearing loss (61%) showed objective hearing improvement within six months of treatme

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::29358d093473ae42ed110cca94211ac8
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=17463

Closing the gap: National Argentinian discussion forum on paediatric brain tumours.

Autor: Baroni LV; Service of Haematology/Oncology, Hospital Juan P. Garrahan, Buenos Aires, Argentina., Fernández Ponce N; Service of Haematology/Oncology, Hospital Juan P. Garrahan, Buenos Aires, Argentina., Freytes C; Service of Haematology/Oncology, Hospital Juan P. Garrahan, Buenos Aires, Argentina., Maldonado FR; Service of Diagnostic Imaging, Hospital Juan P. Garrahan, Buenos Aires, Argentina., Pinto N; Service of Radiotherapy, Hospital Juan P. Garrahan, Buenos Aires, Argentina., González Ramos J; Service of Neurosurgery, Hospital Juan P. Garrahan, Buenos Aires, Argentina., Lubieniecki F; Service of Pathology, Hospital Juan P. Garrahan, Buenos Aires, Argentina., Zubizarreta P; Service of Haematology/Oncology, Hospital Juan P. Garrahan, Buenos Aires, Argentina., Alderete D; Service of Haematology/Oncology, Hospital Juan P. Garrahan, Buenos Aires, Argentina.

Publikováno v: Frontiers in oncology [Front Oncol] 2023 May 18; Vol. 13, pp. 1185766. Date of Electronic Publication: 2023 May 18 (Print Publication: 2023).

The impact of the COVID-19 pandemic in pediatric oncology units: A lesson of resilience and hope.

Autor: Baroni LV; Service of Hematology/Oncology, Hospital J P Garrahan, Combate de los Pozos, Buenos Aires, Argentina., Bouffet E; Division of Haematology/Oncology, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.

Publikováno v: Cancer [Cancer] 2022 Apr 01; Vol. 128 (7), pp. 1363-1364. Date of Electronic Publication: 2022 Jan 24.

Ultra high-risk PFA ependymoma is characterized by loss of chromosome 6q.

Autor: Baroni LV; Division of Haematology/Oncology, Hospital for Sick Children, Toronto, Ontario, Canada.; Programme in Developmental and Stem Cell Biology, Arthur and Sonia Labatt Brain Tumour Research Centre, Hospital for Sick Children, Toronto, Ontario, Canada., Sundaresan L; Programme in Developmental and Stem Cell Biology, Arthur and Sonia Labatt Brain Tumour Research Centre, Hospital for Sick Children, Toronto, Ontario, Canada., Heled A; Programme in Developmental and Stem Cell Biology, Arthur and Sonia Labatt Brain Tumour Research Centre, Hospital for Sick Children, Toronto, Ontario, Canada., Coltin H; Division of Haematology/Oncology, Hospital for Sick Children, Toronto, Ontario, Canada.; Programme in Developmental and Stem Cell Biology, Arthur and Sonia Labatt Brain Tumour Research Centre, Hospital for Sick Children, Toronto, Ontario, Canada., Pajtler KW; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Division of Pediatric Neuro-Oncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany.; Department of Pediatric Oncology and Hematology, University Hospital Heidelberg, Heidelberg, Germany., Lin T; Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Merchant TE; Department of Radiation Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., McLendon R; The Preston Robert Tisch Brain Tumor Center, Duke University, Durham, North Carolina, USA., Faria C; Division of Neurosurgery, Centro Hospitalar Lisboa Norte, Hospital de Santa Maria, Lisbon, Portugal., Buntine M; Hudson Institute of Medical Research, Clayton, Australia., White CL; Hudson Institute of Medical Research, Clayton, Australia., Pfister SM; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Division of Pediatric Neuro-Oncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany.; Department of Pediatric Oncology and Hematology, University Hospital Heidelberg, Heidelberg, Germany., Gilbert MR; Neuro-Oncology Branch, National Cancer Institute, Bethesda, Maryland, USA., Armstrong TS; Neuro-Oncology Branch, National Cancer Institute, Bethesda, Maryland, USA., Bouffet E; Division of Haematology/Oncology, Hospital for Sick Children, Toronto, Ontario, Canada., Kumar S; Programme in Developmental and Stem Cell Biology, Arthur and Sonia Labatt Brain Tumour Research Centre, Hospital for Sick Children, Toronto, Ontario, Canada., Taylor MD; Programme in Developmental and Stem Cell Biology, Arthur and Sonia Labatt Brain Tumour Research Centre, Hospital for Sick Children, Toronto, Ontario, Canada.; Division of Neurosurgery, Hospital for Sick Children, Toronto, Ontario, Canada., Aldape KD; Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Ellison DW; Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Gottardo NG; Department of Paediatric Oncology and Haematology, Perth Children's Hospital, Perth, Australia., Kool M; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Division of Pediatric Neuro-Oncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany.; Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands., Korshunov A; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Division of Pediatric Neuro-Oncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany.; Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Hansford JR; Children's Cancer Centre, Royal Children's Hospital; Murdoch Children's Research Institute; Department of Pediatrics, University of Melbourne; Monash University, Melbourne, Australia., Ramaswamy V; Division of Haematology/Oncology, Hospital for Sick Children, Toronto, Ontario, Canada.; Programme in Developmental and Stem Cell Biology, Arthur and Sonia Labatt Brain Tumour Research Centre, Hospital for Sick Children, Toronto, Ontario, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.

Publikováno v: Neuro-oncology [Neuro Oncol] 2021 Aug 02; Vol. 23 (8), pp. 1360-1370.

[Targeted therapies with BRAF inhibitors for pediatric low- and high-grade gliomas with BRAFv600e mutation. Prof. Dr. Juan P. Garrahan Hospital experience].

Autor: Warriner E; Servicio de Oncología, Hospital de Pediatría SAMIC Prof. Dr. Juan P. Garrahan, Buenos Aires, Argentina. E-mail: ewarriner3@gmail.com., Fernández Ponce N; Servicio de Oncología, Hospital de Pediatría SAMIC Prof. Dr. Juan P. Garrahan, Buenos Aires, Argentina., Freytes C; Servicio de Oncología, Hospital de Pediatría SAMIC Prof. Dr. Juan P. Garrahan, Buenos Aires, Argentina., Sampor C; Servicio de Oncología, Hospital de Pediatría SAMIC Prof. Dr. Juan P. Garrahan, Buenos Aires, Argentina., Oller A; Servicio de Oncología, Hospital de Pediatría SAMIC Prof. Dr. Juan P. Garrahan, Buenos Aires, Argentina., Rugilo C; Servicio de Diagnóstico por Imágenes, Hospital de Pediatría SAMIC Prof. Dr. Juan P. Garrahan, Buenos Aires, Argentina., Lubieniecki F; Servicio de Patología, Hospital de Pediatría SAMIC Prof. Dr. Juan P. Garrahan, Buenos Aires, Argentina., Vazquez V; Servicio de Patología, Hospital de Pediatría SAMIC Prof. Dr. Juan P. Garrahan, Buenos Aires, Argentina., Alderete D; Servicio de Oncología, Hospital de Pediatría SAMIC Prof. Dr. Juan P. Garrahan, Buenos Aires, Argentina., Baroni LV; Servicio de Oncología, Hospital de Pediatría SAMIC Prof. Dr. Juan P. Garrahan, Buenos Aires, Argentina.

Publikováno v: Medicina [Medicina (B Aires)] 2021; Vol. 81 (5), pp. 791-799.